C. Koev

发表

Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.

D. Alling, C. Natanson, S. Banks, 1995, The Journal of pharmacology and experimental therapeutics.

The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure

C. Natanson, L. Cork, P. Eichacker, 1994, The Journal of experimental medicine.

Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs.

C. Natanson, S. Banks, J. Cobb, 1995, The American journal of physiology.

LACK OF PROTECTION BY Nw-METHYL-L-ARGININE (NMA), A NITRIC OXIDE SYNTHASE INHIBITOR, IN ENDOTOXIN (LPS)-CHALLENGED CANINES

C. Natanson, S. Banks, J. Cobb, 1993 .

N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin

C. Natanson, S. Banks, J. Cobb, 1992, The Journal of experimental medicine.

A controlled trial of HA-1A in a canine model of gram-negative septic shock.

D. Alling, C. Natanson, S. Banks, 1993, JAMA.

Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsis.

C. Natanson, S. Banks, R. Danner, 1998, Journal of applied physiology.